Apolipoprotein(a) gene enhancer resides within a LINE element

被引:91
作者
Yang, ZY [1 ]
Boffelli, D [1 ]
Boonmark, N [1 ]
Schwartz, K [1 ]
Lawn, R [1 ]
机构
[1] Stanford Univ, Sch Med, Falk Cardiovasc Res Ctr, Stanford, CA 94305 USA
关键词
D O I
10.1074/jbc.273.2.891
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apolipoprotein(a), (apo(a)), is the distinguishing protein portion of the lipoprotein(a) particle, elevated plasma levels of which are a major risk factor for cardiovascular disease. A search for enhancer elements that control the transcription of the apo(a) gene led to the identification of an upstream element that contains target binding sites for members of the Ets and Sp1 nuclear protein families. The enhancer element functions in either orientation to confer a greater than 10-fold increase in the activity of the apo(a) minimal promoter in cultured hepatocyte cells. Unexpectedly, the enhancer element is located within a LINE retrotransposon element, suggesting that LINE elements may function as mobile regulatory elements to control the expression of nearby genes.
引用
收藏
页码:891 / 897
页数:7
相关论文
共 59 条
  • [1] Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men
    Assmann, G
    Schulte, H
    vonEckardstein, A
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (14) : 1179 - 1184
  • [2] AZROLAN N, 1991, J BIOL CHEM, V266, P13866
  • [3] An Ets/Sp1 interaction in the 5'-flanking region of the megakaryocyte-specific alpha IIb gene appears to stabilize Sp1 binding and is essential for expression of this TATA-less gene
    Block, KL
    Shou, YP
    Poncz, M
    [J]. BLOOD, 1996, 88 (06) : 2071 - 2080
  • [4] APOLIPOPROTEIN(A) GENE ACCOUNTS FOR GREATER THAN 90-PERCENT OF THE VARIATION IN PLASMA LIPOPROTEIN(A) CONCENTRATIONS
    BOERWINKLE, E
    LEFFERT, CC
    LIN, JP
    LACKNER, C
    CHIESA, G
    HOBBS, HH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) : 52 - 60
  • [5] Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger - A prospective study
    Bostom, AG
    Cupples, LA
    Jenner, JL
    Ordovas, JM
    Seman, LJ
    Wilson, PWF
    Schaefer, EJ
    Castelli, WP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (07): : 544 - 548
  • [6] PURIFICATION AND BIOCHEMICAL-CHARACTERIZATION OF THE PROMOTER-SPECIFIC TRANSCRIPTION FACTOR, SPL
    BRIGGS, MR
    KADONAGA, JT
    BELL, SP
    TJIAN, R
    [J]. SCIENCE, 1986, 234 (4772) : 47 - 52
  • [7] THE HUMAN APOLIPOPROTEIN(A) PLASMINOGEN GENE-CLUSTER CONTAINS A NOVEL HOMOLOG TRANSCRIBED IN LIVER
    BYRNE, CD
    SCHWARTZ, K
    MEER, K
    CHENG, JF
    LAWN, RM
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (04): : 534 - 541
  • [8] SEQUENCE POLYMORPHISMS IN THE APOLIPOPROTEIN(A) GENE - EVIDENCE FOR DISSOCIATION BETWEEN APOLIPOPROTEIN(A) SIZE AND PLASMA LIPOPROTEIN(A) LEVELS
    COHEN, JC
    CHIESA, G
    HOBBS, HH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) : 1630 - 1636
  • [9] DEMEESTER CA, 1995, AM J HUM GENET, V56, P287
  • [10] Interaction of human T-cell lymphotropic virus type I Tax, Ets1, and Sp1 in transactivation of the PTHrP P2 promoter
    Dittmer, J
    PiseMasison, CA
    Clemens, KE
    Choi, KS
    Brady, JN
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (08) : 4953 - 4958